Standard Life Euro Pri Eqty Tst PLC
03 October 2006
Standard Life European Private Equity Trust PLC
Disclosure of ten largest holdings at 30 September 2006 as required by the
Listing Rules, Chapter 21 paragraph 20 l.
As at 30 September 2006 the ten largest portfolio holdings of the Company by
value were as follows -
Valuation £'000 % Gross Assets
Alchemy Investment Plan 21,582 7.74%
CVC Europe III 19,040 6.83%
Charterhouse VII 17,803 6.39%
Candover 2001 Fund 15,944 5.72%
Third Cinven Fund 15,815 5.67%
Advent Global Private Equity IV 15,355 5.51%
Barclays Private Equity European Fund 14,863 5.33%
MUST 4 13,497 4.84%
Duke Street Capital V 10,292 3.69%
Apax Europe VI 9,574 3.44%
Total of ten largest portfolio holdings 153,765 55.16%
Gross assets 278,702
As an investor in private equity funds, the Company carries out a valuation of
its unquoted fund investments on a quarterly basis. The above table reflects the
last valuation carried out as of 30 June 2006.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.